Study: Deaths from most common lung cancer fall sharply as treatments advance
Incidence-based mortality for the most common U.S. lung cancer fell about 6% per year between 2013 and 2016 as treatment advances accelerated previous declines, according to a reported this week in the New England Journal of Medicine.
鈥淭his analysis shows for the first time that nationwide mortality rates for the most common category of lung cancer, non-small cell lung cancer, are declining faster than its incidence, an advance that correlates with the U.S. Food and Drug Administration approval of several targeted therapies for this cancer in recent years,鈥 Douglas Lowy, M.D., National Cancer Institute deputy director and co-author of the study.
Related News Articles
Headline
The deadline for health delivery organizations to apply for the AHA鈥檚 2026 Foster G. McGaw Prize is 1 p.m. ET May 6. The award honors organizations that鈥
Headline
A study published March 31 by the National Institutes of Health found that adults living in rural areas have worse cardiovascular health than those in urban鈥
Headline
Cigarette smoking by adults has dropped to its lowest level in 60 years, the Centers for Disease Control and Prevention reported today. Despite that, tobacco鈥
Headline
In this conversation, Mindy Estes, M.D., former CEO of Saint Luke's Health System and former AHA board chair, and Roxanna Gapstur, R.N., CEO of WellSpan Health鈥
Headline
A case study by the AHA's Community Health Improvement network explains how Children鈥檚 Mercy Kansas City created a new model to coordinate its community鈥
Chairperson's File
Trust 鈥 in one another, in our field, and in our communities 鈥 is so important to what we do. Everyone should know that our hospitals and health systems are a鈥